The Market of Life Science Instruments Will Face Explosive Growth

(2021年)

https://www.pharmasources.com/events/cphi-worldwide-2021-2086.html
1. The Market of Life Science Instruments Will Face Explosive Growth

In the early 1980s, it was predicted that the 21st century would be the century of biology. This prediction has now become a reality. Half of the world's top ten scientific and technological breakthroughs in 2014 selected by American weekly Science came from the field of life sciences. In 2014, scientists made many breakthroughs in the fields of aging research, biological evolution, genetic analysis of genetic diseases, stem cells, brain and nerve cells, which will help people reveal the secrets of human growth, development, aging, illness, and death. Finally, these achievements will help people overcome major diseases such as AIDS, cancer, and Ebola.

In China, as one of the seven strategic emerging industries listed in the Decision of the State Council on Accelerating the Cultivation and Development of Strategic Emerging Industries, bio-industry has become the focus of policy and funds in recent years. In 2014, in the 863 and 973 programs, the biological field was still the most invested field. "Bio-industry Development Plan" sets the development goal of keeping the average annual growth rate of bio-industry output value above 20% in recent three years, which indicates that China's bio-industry has entered a period of rapid development. Important fields of bio-industry such as biomedicine and bio-agriculture are bound to receive more related production and R&D investment.

The development of the bio-industry will inevitably bring huge market opportunities for life science instruments which are important tools in the field of life science. Relevant research shows that in 2014, the global sales of life science instruments exceeded USD 40 billion, and increased at a rate of 6%. As for the Chinese market, although the economic growth has slowed down, the Chinese market is still the most powerful driving force for life science instruments due to the increased state support and the huge purchasing demand brought by the vigorous development of the bio-industry.

The market of molecular diagnosis is still one of the hot spots in the field of life sciences. In 2014, the global molecular diagnostic market grew at a speed of over 10%. While the growth rate of China's molecular diagnosis market exceeds 20%. In another hot spot of life science, biological breeding with transgenic technology as the core is the leading factor in the development of biological agriculture in China. The rapid development of these hot spots has driven the purchasing demand for related research tools, such as gene sequencer, PCR, and other molecular cell biology instruments.

Foreign media predict that in the past three years, with the vigorous development of molecular diagnosis, biomedicine, and other fields, genomics-related instruments such as fluorescence quantitative PCR, NGS, 3GS, chip, PCR, CE sequencing, digital PCR, protein separation, and analysis equipment, proteomics instruments such as ELISA, western blotting and protein chip, and cell biology instruments such as flow cytometry and the microscope will create larger market scale.

In view of the vigorous rise of the life science industry, major instrument companies have stepped up their efforts to transform into the life science field. Agilent focuses more on the biomedical field through resolution, in order to achieve greater development in life sciences and diagnostic business. Merck and Danaher have accelerated their expansion into the field of life sciences through acquisition. Brooke's sale of ICP-MS business is one of its important strategies to shift its focus to life sciences. Thus it can be seen that the field of life sciences has become a battleground for major instrument companies.

Find high quality life science instruments, manufacturers and suppliers at pharmasources.com - the largest b2b platform in pharmaceutical industry.

Life science instruments product page:https://www.pharmasources.com/products/catid/laboratory-802.html

GM Diaphragm GM-0.5/0.5A/0.5B/1A
Category:Laboratory
Product Name:GM Diaphragm GM-0.5/0.5A/0.5B/1A
Price(USD):USD250~USD350
Company:Linhai Tan's Vacuum Equipment Co.,Ltd.

Here are some events in pharmaceutical industry:Mimg_1609050752164368.jpg!200

CPhI Worldwide 2021
Time:November 09-11, 2021
Country/Region: Italy
Venue:Fiera Milano, Italy
Organizer:Informa Markets

CPhI Middle East & Africa 2021
Time:March 24-25, 2021
Country/Region: United Arab Emirates
Venue:RICEC | Riyadh, Saudi Arabia
Organizer:Informa Markets

More events, you can find here:https://www.pharmasources.com/events

コメント